Resources

Two investigators found that more than three hours a day would be required for an average type 2 diabetes patient to follow to the letter all home-care tasks recommended by the American Diabetes Association.

Researchers reported that preeclampsia is an independent risk marker for type 2 diabetes, even when gestational diabetes is taken into account.

FOUR studies find that this is true for patients with high blood pressure, and elevated blood sugar.

The first results from an investigational transdermal insulin delivery system suggest that it is possible to deliver insulin through the skin.

Postmenopausal women with high levels of estradiol and testosterone are at a greatly increased risk of developing type 2 diabetes, according to data on nearly 28,000 women.

In the first human trials of oral insulin, the drug acted within 15 minutes and showed 60%-70% of the biopotency of injected insulin, without causing any adverse effects, researchers reported here at the 66th Scientific Sessions of the American Diabetes Association.

Researchers reported that, Januvia (sitagliptin), an investigational oral agent for type 2 diabetes, appears to be effective when given as a monotherapy or as an adjunct to Glucophage (metformin) or Actos (pioglitazone). FDA approval expected soon.

Study shows an innovative mealtime insulin dosing algorithm provides alternative to carb counting for Type 2’s

ADA:BYETTA(R) Extension Study Results Shows Sustained Improvements in Blood Glucose Control and Progressive Weight Loss After Two Years Patients sustained an average hemoglobin A1C (A1C) reduction of 1.1 percent from baseline and Average weight loss improved to 10 pounds from the average of five pounds seen after 30 weeks. Fasting …

Most patients saw improvements in three critical measures of blood glucose control